Jacobson Pharma Corporation Limited 2633.HK Stock
Jacobson Pharma Corporation Limited Price Chart
Jacobson Pharma Corporation Limited 2633.HK Financial and Trading Overview
| Jacobson Pharma Corporation Limited stock price | 0.57 HKD |
| Previous Close | 0.99 HKD |
| Open | 1.04 HKD |
| Bid | 1.01 HKD x 0 |
| Ask | 1.04 HKD x 0 |
| Day's Range | 0.97 - 1.05 HKD |
| 52 Week Range | 0.61 - 1.11 HKD |
| Volume | 2.59M HKD |
| Avg. Volume | 194.62K HKD |
| Market Cap | 1.98B HKD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 8.666667 |
| EPS (TTM) | 0.11 HKD |
| Forward Dividend & Yield | 0.06 (5.70%) |
| Ex-Dividend Date | August 15, 2023 |
| 1y Target Est | N/A |
2633.HK Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 8.666667 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.78313255 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Jacobson Pharma Corporation Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 59.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.11 HKD |
| 52 Week Low | 0.61 HKD |
| 50-Day Moving Average | 0.93 HKD |
| 200-Day Moving Average | 0.9 HKD |
2633.HK Share Statistics
| Avg. Volume (3 month) | 194.62K HKD |
| Avg. Daily Volume (10-Days) | 161.41K HKD |
| Shares Outstanding | 1.9B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 81.57% |
| % Held by Institutions | 0.34% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 369.00% |
| Payout Ratio | 0.3183 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 747.17M HKD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.328 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Jacobson Pharma Corporation Limited
| Country | Hong Kong |
| State | N/A |
| City | Kwun Tong |
| Address | Tower 1, Millennium City 1 |
| ZIP | N/A |
| Phone | 852 2267 2298 |
| Website | https://www.jacobsonpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
Q&A For Jacobson Pharma Corporation Limited Stock
What is a current 2633.HK stock price?
Jacobson Pharma Corporation Limited 2633.HK stock price today per share is 0.57 HKD.
How to purchase Jacobson Pharma Corporation Limited stock?
You can buy 2633.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jacobson Pharma Corporation Limited?
The stock symbol or ticker of Jacobson Pharma Corporation Limited is 2633.HK.
Which industry does the Jacobson Pharma Corporation Limited company belong to?
The Jacobson Pharma Corporation Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Jacobson Pharma Corporation Limited have in circulation?
The max supply of Jacobson Pharma Corporation Limited shares is 2B.
What is Jacobson Pharma Corporation Limited Price to Earnings Ratio (PE Ratio)?
Jacobson Pharma Corporation Limited PE Ratio is 5.18181800 now.
What was Jacobson Pharma Corporation Limited earnings per share over the trailing 12 months (TTM)?
Jacobson Pharma Corporation Limited EPS is 0.11 HKD over the trailing 12 months.
Which sector does the Jacobson Pharma Corporation Limited company belong to?
The Jacobson Pharma Corporation Limited sector is Healthcare.